Literature DB >> 7980503

Rapid effects of aldosterone on free intracellular calcium in vascular smooth muscle and endothelial cells: subcellular localization of calcium elevations by single cell imaging.

M Wehling1, A Ulsenheimer, M Schneider, C Neylon, M Christ.   

Abstract

Rapid in vitro effects of aldosterone on the intracellular concentrations of sodium, potassium and calcium, cell volume and the sodium-proton-antiport have been described in human mononuclear leukocytes and vascular smooth muscle cells (VSMC). These nongenomic effects are signalled through membrane receptors with a high affinity for aldosterone, but not for cortisol, and through the phosphoinositide pathway. In the present study, we demonstrate that free intracellular calcium is increased rapidly by aldosterone in VSMC and endothelial cells (EC) as determined by single cell imaging of Fura2-fluorescence. In VSMC, calcium elevation is localized to the perinuclear region whereas in EC, a predominant increase of subplasmalemmal calcium is seen. In VSMC, effects are half maximal at 0.1 nM aldosterone; cortisol is inactive up to 0.1 microM. These data show that intracellular signalling for aldosterone also involves calcium, but the subcellular localization of this signal varies between cell types.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7980503     DOI: 10.1006/bbrc.1994.2484

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

Review 1.  Aldosterone antagonists in the treatment of hypertension and target organ damage.

Authors:  S Rajagopalan; B Pitt
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

2.  Intracellular calcium: a prerequisite for aldosterone action.

Authors:  C Schäfer; V Shahin; L Albermann; H Schillers; M J Hug; H Oberleithner
Journal:  J Membr Biol       Date:  2003-12-01       Impact factor: 1.843

Review 3.  Effects of aldosterone and mineralocorticoid receptor blockade on intracellular electrolytes.

Authors:  Martin Wehling
Journal:  Heart Fail Rev       Date:  2005-01       Impact factor: 4.214

4.  Rapid and non-genomic reduction of intracellular [Ca(2+)] induced by aldosterone in human bronchial epithelium.

Authors:  V Urbach; B J Harvey
Journal:  J Physiol       Date:  2001-11-15       Impact factor: 5.182

Review 5.  Comparison of the mechanisms of nongenomic actions of thyroid hormone and steroid hormones.

Authors:  P J Davis; H C Tillmann; F B Davis; M Wehling
Journal:  J Endocrinol Invest       Date:  2002-04       Impact factor: 4.256

6.  Aldosterone signaling pathway across the nuclear envelope.

Authors:  C Schäfer; V Shahin; L Albermann; M J Hug; J Reinhardt; H Schillers; S W Schneider; H Oberleithner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

7.  Chemical modification and structural analysis of the progesterone membrane binding protein from porcine liver membranes.

Authors:  E Falkenstein; C Eisen; K Schmieding; M Krautkrämer; C Stein; R Lösel; M Wehling
Journal:  Mol Cell Biochem       Date:  2001-02       Impact factor: 3.396

Review 8.  Looking beyond the dogma of genomic steroid action: insights and facts of the 1990s.

Authors:  M Wehling
Journal:  J Mol Med (Berl)       Date:  1995-09       Impact factor: 4.599

9.  Non-genomic regulation of intermediate conductance potassium channels by aldosterone in human colonic crypt cells.

Authors:  K A Bowley; M J Morton; M Hunter; G I Sandle
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

Review 10.  Cerebro-Cardiovascular Risk, Target Organ Damage, and Treatment Outcomes in Primary Aldosteronism.

Authors:  Xiao Lin; Muhammad Hasnain Ehsan Ullah; Xiong Wu; Feng Xu; Su-Kang Shan; Li-Min Lei; Ling-Qing Yuan; Jun Liu
Journal:  Front Cardiovasc Med       Date:  2022-02-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.